Where Pharma Wins: Jaswinder Chadha on How Axtria Uses AI to Drive Commercial Ops and Outcomes

What separates life sciences leaders from the rest of the market? In an era defined by data abundance and rapid innovation, the answer lies in how effectively companies turn insight into action.

In this podcast, Jaswinder “Jassi” Chadha, President and CEO of Axtria, shares a visionary perspective on how artificial intelligence is transforming pharmaceutical commercial operations—from identifying patients with unmet needs to enabling faster, smarter, and more personalized engagement across the healthcare ecosystem.

Drawing on nearly 30 years of industry experience, Jassi explains why many breakthrough therapies still struggle to succeed commercially—and how AI, when embedded directly into real-world workflows, can unlock measurable impact. The conversation explores Axtria’s evolution into an AI-driven enterprise platform, the launch of InsightsMAx, and the shift from traditional analytics to outcome-oriented, agent-based decision systems.

This episode offers a compelling look at how AI is no longer experimental in life sciences—but a strategic imperative for companies aiming to win in the market and deliver better patient outcomes.

In this podcast, we cover:

• Why commercial execution—not scientific innovation alone—determines pharma success
• How AI is enabling precision engagement across patient, provider, and field sales journeys
• Turning data into decisions through metadata, knowledge graphs, and AI agents
• Operationalizing AI at scale with no-code and low-code platforms
• Embedding intelligence directly into CRM and commercial workflows
• Real-world examples of AI driving patient identification and revenue uplift
• The evolving role of consulting in an AI-first, outcome-driven world
• Navigating data privacy, governance, and regulatory complexity in global healthcare
• How AI will shape the next decade of pharma commercialization and rare disease treatment

Key takeaways

• AI delivers value when it drives action—not just insight
  

  The most impactful AI systems are embedded into everyday workflows, enabling faster decisions and real execution at scale.

• Domain expertise is the true differentiator
  

  AI becomes powerful when combined with deep life sciences knowledge, contextual data models, and industry-specific workflows.

• Speed, accuracy, and agility define modern commercial excellence
  

  Leading pharma companies are moving from days to hours in decision-making, with significant gains in quality and efficiency.

• Patient-centricity is now operational, not aspirational
  

  AI enables pharma organizations to identify unmet needs earlier and engage patients and providers with greater precision.

• The future of pharma is personalized and AI-powered
  

  As treatments become more targeted and disease segments smaller, AI will be essential to scale personalization sustainably.